EDITORIAL
Accepted on 29 Aug 2025
Editorial: Advances in Understanding and Managing Systemic Sclerosis-Associated Interstitial Lung Disease: Bridging Prognostic Biomarkers to Therapeutic Innovations
doi 10.3389/fmed.2025.1683554
- 361 views
- Frontiers in Medicine
- Rheumatology
- Research Topics
- Advances in Understanding and Managing Systemic Sclerosis-Associated Interstitial Lung Disease: Bridging Prognostic Biomarkers to Therapeutic Innovations
Advances in Understanding and Managing Systemic Sclerosis-Associated Interstitial Lung Disease: Bridging Prognostic Biomarkers to Therapeutic Innovations
950
Total downloads
7,312
Total views and downloads
Articles
ORIGINAL RESEARCH
Published on 13 Aug 2025
A comparative analysis of cardiopulmonary features in patients with systemic sclerosis and mixed connective tissue disease: results from SOPHIE registry
doi 10.3389/fmed.2025.1626546
- 1,144 views
ORIGINAL RESEARCH
Published on 09 Jul 2025
The association between high atherogenic index of plasma and impaired lung function: a population-based study
doi 10.3389/fmed.2025.1589605
- 1,310 views
ORIGINAL RESEARCH
Published on 08 May 2025
Identifying inflammatory phenotypes associated with lung involvement in systemic sclerosis: k-means clustering approach
doi 10.3389/fimmu.2025.1568683
- 1,348 views
ORIGINAL RESEARCH
Published on 30 Apr 2025
Circulating extracellular vesicles as predictive biomarkers of progressive interstitial lung disease in systemic sclerosis—a prospective cohort study
doi 10.3389/fmed.2025.1594201
- 1,094 views
Published in
Frontiers in Medicine
Rheumatology
Pulmonary Medicine
Participating Journals
Frontiers in Immunology
- 5.9 impact factor
- 10.8 citescore